{"id":20457,"date":"2023-10-11T11:29:33","date_gmt":"2023-10-11T09:29:33","guid":{"rendered":"https:\/\/ggba.swiss\/?p=20457"},"modified":"2023-10-11T11:29:35","modified_gmt":"2023-10-11T09:29:35","slug":"adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/","title":{"rendered":"Adiposs completes the phase I clinical trial of its flagship product ImageBAT"},"content":{"rendered":"\n<p>A notable spin-off from the University of Geneva, and materializing from a landscape where every year 41,700 new cancer cases are identified in Switzerland alone, <a href=\"https:\/\/adiposs.com\/\">Adiposs<\/a> is specialized in combatting the clandestine syndrome of cachexia affecting 25% of cancer patients indirectly through muscle and adipose tissue wastage.<\/p>\n\n\n\n<p>Its flagsip product <a href=\"https:\/\/adiposs.com\/technology\/\">ImageBAT<\/a>, envisioned to be a paramount diagnostic tool in cancer management, delivers non-invasive visualization and quantification of activated brown fat, which when in excess, propels hypermetabolism correlated to treatment failure in cancer patients. A step further, its conception was largely driven by an ambition to detect cachexia before weight and muscle wastage occur, a previously elusive feat in medical science.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Q&amp;A with Adiposs (Fongit Innovation Fund)\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/4Y7CFWuH3sM?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p>Dr. Andrej Babic, CEO and co-founder, commented: \u201cThe completion of the Phase I clinical trial is a major milestone for Adiposs.\u201d Underlying this trial was a meticulous assessment of ImageBAT involving thirty healthy subjects, revealing promising aspects of tolerability and safety without any severe adverse episodes. Equally noteworthy, Dr. Herv\u00e9 Porchet, Chief Medical Officer, explained: &nbsp;\u201cThe levels of exposure to ImageBAT and pharmacokinetics were comparable in healthy subjects and our preclinical studies.\u201d<\/p>\n\n\n\n<p>The serendipitous stride in successfully maneuvering through the pre-clinical development phase, achieving <a href=\"https:\/\/ggba.swiss\/en\/university-of-geneva-spin-off-adiposs-combats-cancer-cachexia\/\">robust proof-of-concept studies in 2020<\/a>, and securing various accolades and financial backings such as the CHF 100,000 Tech Seed loan from the Foundation for Technological Innovation (<a href=\"https:\/\/www.fondation-fit.ch\/en\/\">FIT<\/a>), has greatly contributed to Adiposs\u2019 success. The trajectory towards Phase II, slated for 2024 and focusing on patients with advanced lung cancer in Europe, is eagerly anticipated. Reinhard Stary, Chairman of the Board, expressed: \u201cWe are very excited at the perspective of using ImageBAT in cancer patients for the first time and making headway on our mission to improve the lives of cancer patients worldwide.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Phase I clinical trial for its innovative product, ImageBAT.<\/p>\n","protected":false},"author":6,"featured_media":20458,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[908,894,883],"class_list":["post-20457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-diagnostic","tag-financing","tag-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adiposs completes the phase I clinical trial of ImageBAT | GGBa<\/title>\n<meta name=\"description\" content=\"Adiposs has succesfully completed the Phase I clinical trial for its innovative flagship product, ImageBAT.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adiposs completes the phase I clinical trial of ImageBAT | GGBa\" \/>\n<meta property=\"og:description\" content=\"Adiposs has succesfully completed the Phase I clinical trial for its innovative flagship product, ImageBAT.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-11T09:29:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-11T09:29:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Adiposs completes the phase I clinical trial of its flagship product ImageBAT\",\"datePublished\":\"2023-10-11T09:29:33+00:00\",\"dateModified\":\"2023-10-11T09:29:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/\"},\"wordCount\":303,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg\",\"keywords\":[\"Diagnostic\",\"Financing\",\"Oncology\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/\",\"url\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/\",\"name\":\"Adiposs completes the phase I clinical trial of ImageBAT | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg\",\"datePublished\":\"2023-10-11T09:29:33+00:00\",\"dateModified\":\"2023-10-11T09:29:35+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Adiposs has succesfully completed the Phase I clinical trial for its innovative flagship product, ImageBAT.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Adiposs pioneers a new era in cancer patient care with a pivotal leap towards making ImageBAT a revolutionary tool in detecting hypermetabolism. | \u00a9 Adiposs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adiposs completes the phase I clinical trial of its flagship product ImageBAT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adiposs completes the phase I clinical trial of ImageBAT | GGBa","description":"Adiposs has succesfully completed the Phase I clinical trial for its innovative flagship product, ImageBAT.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/","og_locale":"en_US","og_type":"article","og_title":"Adiposs completes the phase I clinical trial of ImageBAT | GGBa","og_description":"Adiposs has succesfully completed the Phase I clinical trial for its innovative flagship product, ImageBAT.","og_url":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-10-11T09:29:33+00:00","article_modified_time":"2023-10-11T09:29:35+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Adiposs completes the phase I clinical trial of its flagship product ImageBAT","datePublished":"2023-10-11T09:29:33+00:00","dateModified":"2023-10-11T09:29:35+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/"},"wordCount":303,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg","keywords":["Diagnostic","Financing","Oncology"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/","url":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/","name":"Adiposs completes the phase I clinical trial of ImageBAT | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg","datePublished":"2023-10-11T09:29:33+00:00","dateModified":"2023-10-11T09:29:35+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Adiposs has succesfully completed the Phase I clinical trial for its innovative flagship product, ImageBAT.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Adiposs-ImageBAT-1180x811-1.jpg","width":1180,"height":811,"caption":"Adiposs pioneers a new era in cancer patient care with a pivotal leap towards making ImageBAT a revolutionary tool in detecting hypermetabolism. | \u00a9 Adiposs"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/adiposs-completes-the-phase-i-clinical-trial-of-its-flagship-product-imagebat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Adiposs completes the phase I clinical trial of its flagship product ImageBAT"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/20457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=20457"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/20457\/revisions"}],"predecessor-version":[{"id":20462,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/20457\/revisions\/20462"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/20458"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=20457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=20457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=20457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}